EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Time to first recurrent thrombosis in adults with thrombotic antiphospholipid syndrome: a registry-based retrospective cohort study

María Clara Escobar-Millán, Simón Correa-Sierra, Sebastian Hoyos-Gutierrez, Laura Lopez-Correa, Carolina Ochoa-Gallego, Diana Rocío Gil Calderón, Juan Camilo Díaz-Coronado, Diego Fernando Rojas-Gualdrón

Clinical Rheumatology · 2026-11 · 45 (11) · 6755-6767

DOI: 10.1007/s10067-026-08372-9 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Rheumatology, online erschienen am 08.09.2026. Verfasst von María Clara Escobar-Millán und 7 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ciencias de La Salud, Universidad CES, Calle 10ª # 22-04 Bloque C Piso 2 Facultad de Ciencias de la Salud, Medellín, Colombia. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Thrombosis. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CES University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To estimate time to first recurrent thrombosis and to explore the association between recurrent thrombosis and clinical, laboratory/immunological, and treatment-related factors among Colombian adults with thrombotic antiphospholipid syndrome (APS) enrolled in the ARTMEDICA autoimmune diseases program (2013–2024).

Methods

We conducted a registry-based retrospective follow-up study of patients with thrombotic APS. Patients were followed from the index thrombotic event to the first recurrent arterial or venous thrombosis. Time-to-event analyses used interval-censored parametric survival regression with a log-logistic distribution. To explore factors associated with recurrence, we also applied a matched nested case–control design using conditional logistic regression.

Results

We included 355 patients (mean follow-up 6.6 years), 71.0% female, median age 47 years (IQR 32–60). Primary APS accounted for 83.4% of cases, and the index event was arterial in 72.1%. During follow-up, 130 patients experienced a first thrombotic recurrence: 70.8% venous. The 10-year probability of first recurrence was 42% (95% CI 28.4–55.5%), with 20% (95% CI 10.5–29.1%) during the first 2 years. In the nested case–control, recurrent thrombosis was significantly associated with the LA + /aCL + /antiβ2GPI − profile (OR 4.8; p = 0.044), male sex (OR 1.8; p = 0.038), prior gestational death (OR 2.4; p = 0.008), and ANA positivity (OR 2.4; p = 0.015).

Conclusions

The risk of recurrent thrombosis was highest during the first 2 years after the index thrombotic event, supporting an early vulnerable phase and underscoring the need for closer clinical surveillance and secondary prevention. Limitations of the study include its retrospective design, the lack of standardized anticoagulation monitoring and residual confounding. Key Points • Thrombotic APS carries a high early recurrence burden despite anticoagulation, particularly during the first 2 years after the index event. • Early identification of high-risk patients and intensive surveillance may be critical to prevent recurrent thrombosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiphospholipid SyndromeThrombosisHumansFemaleMaleMiddle AgedRetrospective StudiesRecurrenceRegistriesAdultCase-Control StudiesFollow-Up StudiesTime FactorsRisk FactorsColombia

Stichwörter der Autor:innen

Antiphospholipid syndromeAutoimmune diseasesRecurrenceThrombosis

Autor:innen und Institutionen

  • Facultad de Ciencias de La Salud, Universidad CES, Calle 10ª # 22-04 Bloque C Piso 2 Facultad de Ciencias de la Salud, Medellín, Colombia.
  • ARTMEDICA IPS, Medellín, Colombia.
  • Hospital Universitario Mayor-MEDERI - Universidad El Rosario, Bogotá, Colombia.
  • Facultad de Ciencias de La Salud, Universidad CES, Calle 10ª # 22-04 Bloque C Piso 2 Facultad de Ciencias de la Salud, Medellín, Colombia. dfrojas@ces.edu.co.

Förderung

  • CES University

Zitieren

APA

Escobar-Millán, M. C., Correa-Sierra, S., Hoyos-Gutierrez, S., Lopez-Correa, L., Ochoa-Gallego, C., Gil Calderón, D. R., Díaz-Coronado, J. C., & Rojas-Gualdrón, D. F. (2026). Time to first recurrent thrombosis in adults with thrombotic antiphospholipid syndrome: a registry-based retrospective cohort study. Clinical Rheumatology, 45(11), 6755-6767. https://doi.org/10.1007/s10067-026-08372-9

Vancouver

Escobar-Millán MC, Correa-Sierra S, Hoyos-Gutierrez S, Lopez-Correa L, Ochoa-Gallego C, Gil Calderón DR, et al. Time to first recurrent thrombosis in adults with thrombotic antiphospholipid syndrome: a registry-based retrospective cohort study. Clinical Rheumatology. 2026;45(11):6755-6767. doi:10.1007/s10067-026-08372-9

BibTeX
@article{EscobarMilln2026,
  author = {Escobar-Millán, María Clara and Correa-Sierra, Simón and Hoyos-Gutierrez, Sebastian and Lopez-Correa, Laura and Ochoa-Gallego, Carolina and Gil Calderón, Diana Rocío and Díaz-Coronado, Juan Camilo and Rojas-Gualdrón, Diego Fernando},
  title = {Time to first recurrent thrombosis in adults with thrombotic antiphospholipid syndrome: a registry-based retrospective cohort study},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {11},
  pages = {6755--6767},
  doi = {10.1007/s10067-026-08372-9}
}
Kostenlos starten →